Clinical Trial Update: Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing Saccharomyces boulardii for diarrhea-dominant irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Aga Khan University | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: UNKNOWN